What is a named patient medicine?

Idis excels in creating ethical and responsible frameworks to manage access to named patient medicines, including products that:

• Are still undergoing clinical trials
• Have been launched in one country, but not in the required market
• Are discontinued worldwide
• Are alternatives to medicines discontinued in only certain markets
• Will never gain a licence
• Are an alternative to a medicine experiencing supply shortages
• Have a lapsed marketing authorisation licence